Dr. Chiapperino is the Director of the Controlled Substance Staff (CSS), a group with expertise in the assessment of the abuse potential of drugs.  He has worked extensively on FDA policy and regulatory issues involving cannabis and related substances and, prior to CSS, was with CDER’s Division of Anesthesia, Analgesia, and Addiction Products gaining regulatory experience concerning opioids analgesics and drugs indicated for the treatment of substance use disorders.  He received his PhD in organic chemistry from the University…Read more

Drug Regulatory Control Consultant, former Deputy Secretary of the International Narcotics Control Board (INCB), former Chief of the Narcotics Control and Estimates Section of the Secretariat of INCB at the United Nations Office on Drugs and Crime (UNODC), contributor to several UN and WHO publications. Read more

Rob is an experienced communications executive, healthcare strategist, and leader of cross-functional teams. Rob and his Havas team serve to advance the understanding of cannabinoid health and wellness, with science-based education and communication programs that frame and elevate the cannabinoid conversation, and increase understanding of cannabinoid treatments and ECS-related medical conditions. Read more